The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence.

Prejac, Juraj; Tomek Hamzic, Dora; Librenjak, Niksa; Gorsic, Irma; Kekez, Domina; Plestina, Stjepko

Prejac, Juraj; Tomek Hamzic, Dora; Librenjak, Niksa; Gorsic, Irma; Kekez, Domina; Plestina, Stjepko.

Afiliação

Prejac J; University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.
Tomek Hamzic D; University of Zagreb, School of Dental Medicine, Zagreb, Croatia.
Librenjak N; University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.
Gorsic I; University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.
Kekez D; University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.
Plestina S; University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.

Medicine (Baltimore) ; 101(39): e30566, 2022 Sep 30.

Article em En | MEDLINE | ID: mdl-36181099

Assuntos

Adenocarcinoma; Neoplasias Pancreáticas; Adenocarcinoma/patologia; Idoso; Albuminas; Protocolos de Quimioterapia Combinada Antineoplásica; Desoxicitidina/análogos & derivados; Humanos; Paclitaxel; Neoplasias Pancreáticas/patologia; Estudos Retrospectivos; Resultado do Tratamento; Gencitabina; Neoplasias Pancreáticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google